Barclays Maintains Overweight on HealthStream, Raises Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Barclays has maintained its Overweight rating on HealthStream and increased the price target from $32 to $34.
October 23, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays has reaffirmed its positive outlook on HealthStream by maintaining an Overweight rating and increasing the price target from $32 to $34, indicating confidence in the company's future performance.
The increase in price target from $32 to $34 by Barclays suggests a positive outlook on HealthStream's future performance. Maintaining an Overweight rating indicates that Barclays expects the stock to outperform the market, which could lead to a short-term increase in stock price as investors react to this positive analyst sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100